Changes in non-malignant B cells mirrored those in CLL cells (albeit with a weaker NF-κB signature), while CD4+ T cells, CD8+ T cells, NK cells, and myeloid cells responded in cell type specific ways. The gene discussed is NFKB1; the disease is B-cell chronic lymphocytic leukemia.